Table 3. Best SNP×SNP interactions validated in the phase II and meta-analysis results.
NXC- GWAS | NXC-Val | Pooled analysis | ||||||
CHR | Gene† | SNP pair | OR | p | OR | p | OR | p |
6.22p/10.q22.3 | ATXN1/ANXA11 | rs9464886 AG rs2784773 AA | 2.70 | 1.07E-07 | 1.52 | 0.009628 | 1.88103 | 9.27E-08 |
2q35/4q26 | MREG/NDST3 | rs3770542 AA rs1023890 GG | 2.28 | 7.63E-07 | 1.59 | 0.000762 | 1.73924 | 1.00E-07 |
7q31.33/19q12 | GPR37/LOC100420587 | rs1100508 CG rs8111948 AA | 3.16 | 1.40E-09 | 1.73 | 0.001048 | 2.22646 | 4.35E-11 |
12p11.22/21q22.12 | FAR2/DOPEY2 | rs4931122 AA rs7280997 TT | 2.85 | 3.40E-09 | 1.59 | 0.007512 | 2.16412 | 1.28E-10 |
12q14.1/12q23.1 | FAM19A2/AK307646 | rs2731402 CC rs17375557 AG | 2.20 | 1.34E-06 | 1.50 | 0.005473 | 1.73009 | 2.49E-07 |
SNP: Single Nucleotide Polymorphism; OR: HFCC Odds Ratio; P: value associated with HFCC OR (1 df).
The nearest gene or the gene where the SNP is located.